Bluebird Bio



Ebit Cambiamento Data
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Novartis USD -9.19B 13.87B 2025-06
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Bluebird Bio - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.